Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
22.59
Dollar change
+0.80
Percentage change
3.67
%
IndexRUT P/E- EPS (ttm)-24.21 Insider Own2.06% Shs Outstand57.19M Perf Week2.50%
Market Cap1.29B Forward P/E6.61 EPS next Y3.42 Insider Trans1.99% Shs Float56.01M Perf Month-18.42%
Enterprise Value2.70B PEG0.63 EPS next Q0.84 Inst Own113.74% Short Float14.53% Perf Quarter-28.26%
Income-1.37B P/S0.58 EPS this Y12.62% Inst Trans-4.83% Short Ratio8.23 Perf Half Y-20.79%
Sales2.23B P/B0.64 EPS next Y6.81% ROA-27.39% Short Interest8.14M Perf YTD-15.20%
Book/sh35.33 P/C38.43 EPS next 5Y10.52% ROE-51.11% 52W High47.26 -52.20% Perf Year-52.05%
Cash/sh0.59 P/FCF56.74 EPS past 3/5Y- -4.65% ROIC-40.00% 52W Low21.00 7.57% Perf 3Y-64.96%
Dividend Est.- EV/EBITDA9.61 Sales past 3/5Y13.90% -8.73% Gross Margin51.54% Volatility5.84% 5.56% Perf 5Y-65.78%
Dividend TTM- EV/Sales1.21 EPS Y/Y TTM-1016.39% Oper. Margin-0.48% ATR (14)1.22 Perf 10Y-40.68%
Dividend Ex-Date- Quick Ratio1.16 Sales Y/Y TTM11.57% Profit Margin-61.22% RSI (14)42.22 Recom1.25
Dividend Gr. 3/5Y- - Current Ratio2.22 EPS Q/Q-1664.17% SMA20-3.70% Beta1.25 Target Price45.09
Payout- Debt/Eq0.71 Sales Q/Q8.65% SMA50-13.12% Rel Volume0.86 Prev Close21.79
Employees7367 LT Debt/Eq0.69 EarningsFeb 26 BMO SMA200-24.65% Avg Volume988.84K Price22.59
IPOMay 08, 2008 Option/ShortYes / Yes EPS/Sales Surpr.15.56% 1.91% Trades Volume846,760 Change3.67%
Date Action Analyst Rating Change Price Target Change
Jan-06-26Initiated BTIG Research Buy $41
Oct-03-24Initiated JMP Securities Mkt Outperform $62
Jun-13-24Initiated JP Morgan Neutral $53
Feb-13-24Initiated Stephens Overweight $72
Jan-22-24Initiated UBS Buy $75
Jan-03-24Initiated William Blair Outperform
Dec-15-23Reiterated Needham Buy $62 → $70
Oct-20-23Initiated ROTH MKM Buy $75
Jun-26-23Initiated Needham Buy $70
May-12-23Upgrade Wells Fargo Equal Weight → Overweight $55 → $67
Feb-03-26 08:00AM
Jan-23-26 08:30AM
Jan-22-26 10:21PM
Jan-20-26 10:23AM
Jan-08-26 07:30AM
04:15PM Loading…
Jan-05-26 04:15PM
Dec-17-25 01:01PM
Nov-21-25 06:35PM
Nov-13-25 11:01PM
12:35AM
Nov-12-25 10:35PM
Nov-09-25 11:45PM
Nov-07-25 09:55AM
Nov-06-25 08:53AM
07:15AM
06:14AM Loading…
06:14AM
06:01AM
Nov-04-25 10:18PM
Oct-24-25 04:11PM
Oct-14-25 01:06PM
Oct-08-25 01:45PM
08:15AM
Sep-08-25 04:05PM
Sep-03-25 09:55AM
Aug-27-25 12:00AM
Aug-26-25 11:35PM
Aug-18-25 09:55AM
Aug-14-25 01:34AM
Aug-13-25 12:08PM
Aug-12-25 03:24AM
09:00AM Loading…
Aug-08-25 09:00AM
Aug-07-25 02:06PM
07:20AM
06:15AM
06:00AM
Aug-05-25 11:04PM
Jul-28-25 12:04AM
Jul-21-25 01:16PM
Jul-18-25 03:10PM
Jul-16-25 09:39AM
Jul-08-25 04:05PM
Jun-27-25 05:38AM
Jun-24-25 05:42PM
Jun-06-25 04:05PM
May-15-25 11:31PM
May-09-25 03:16AM
May-08-25 07:30AM
06:29AM
06:00AM
May-07-25 06:00PM
11:15AM
May-02-25 12:34AM
Apr-29-25 09:02AM
Apr-22-25 09:06AM
Apr-18-25 05:16AM
Apr-17-25 07:00AM
Apr-07-25 04:33AM
Apr-02-25 06:30AM
Mar-31-25 09:02AM
Mar-27-25 10:35PM
Mar-25-25 08:00AM
Mar-18-25 09:02AM
Mar-05-25 04:05PM
Feb-27-25 02:09AM
01:11AM
Feb-26-25 07:15AM
06:43AM
06:21AM
06:01AM
06:00AM
Feb-25-25 08:11AM
Jan-29-25 07:00AM
Jan-17-25 06:00AM
Jan-08-25 10:36AM
Jan-07-25 06:19PM
06:19PM
Jan-06-25 04:15PM
Nov-18-24 04:10PM
Nov-08-24 12:00PM
09:55AM
Nov-07-24 02:10AM
12:58AM
Nov-06-24 07:15AM
06:17AM
06:00AM
Oct-31-24 12:02PM
04:32AM
Oct-10-24 07:00AM
Oct-03-24 03:39PM
Sep-09-24 03:50PM
Sep-05-24 08:00AM
05:29AM
Aug-20-24 11:54AM
08:00AM
05:52AM
Aug-19-24 08:00AM
Aug-12-24 04:10PM
04:12AM
Aug-08-24 05:11AM
Aug-07-24 07:15AM
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRYOR DANIEL AFormer EVP, Strategy & Bus DevDec 09 '25Sale27.2099927,1760Dec 11 09:00 PM
PRYOR DANIEL AFormer EVP, Strategy & Bus DevDec 09 '25Sale27.2166618,122160,449Dec 11 09:00 PM
KLECKNER JOHNPrincipal Accounting OfficerNov 25 '25Buy30.322,46874,83012,302Nov 28 04:30 PM
McDonald DamienChief Executive OfficerSep 11 '25Buy30.976,457199,973102,753Sep 11 05:59 PM
Tandy Bradley JSVP and Chief Legal OfficerAug 22 '25Buy31.413,200100,51243,515Aug 25 06:30 AM
BERRY PHILLIP BENJAMIN (BEN)SVP, Chief Financial OfficerAug 20 '25Buy29.712,50074,275116,729Aug 20 05:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Aug 13 '25Buy28.9010,000289,000161,115Aug 14 04:05 PM